Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Merck Global Health Innovation Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 96
Average round size
info
The average size of a deal this fund participated in
$27M
Portfolio companies 56
Rounds per year 6.86
Lead investments 11
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.42
Exits 22
Key employees 6

Areas of investment

  • Health Care
  • Medical
  • Biotechnology
  • Information Technology
  • Software

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Merck Global Health Innovation Fund:
Typical Co-investors
Merck Global Health Innovation Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Merck Global Health Innovation Fund:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Able Partners New York, New York, United States
Arthavida Ventures -
Daun Penh Cambodia Group -
Ecosummit Berlin, Berlin, Germany
Furneaux Capital Boston, Massachusetts, United States
GKN Redditch, United Kingdom, Worcestershire
Goodwood Capital Fund Canada, Ontario, Toronto
Greater Bay Area Homeland Development Fund China, Hong Kong, Hong Kong Island
Grupo Entregas -
Houde Qianhai Fund China, Guangdong, Shenzhen
Jasper Private Equity Birmingham, England, United Kingdom
Javest Investment Fund Amsterdam, Noord-Holland, The Netherlands
Key Fund England, Sheffield, United Kingdom
Madrona Venture Labs Seattle, United States, Washington
Mayo Clinic Ventures Minnesota, Rochester, United States
Ollerhead Capital -
Service Electric Cablevision -
SINOCHEM GROUP Beijing, Beijing, China
Snapdeal Gurgaon, Haryana, India

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Unnatural Products

Artificial Intelligence
Biotechnology
Health Care
$32M19 Dec 2023 California, United States

Culmination Bio

Biotechnology
Health Care
$10M30 Nov 2023 -

Octave Bioscience

Biotechnology
Clinical Trials
Health Care
Health Diagnostics
Medical
$32M26 Jul 2023 California, United States

VastBiome

Biotechnology
Predictive Analytics
Therapeutics
$10M23 Mar 2023 California, United States

IndyGeneUS AI

Biotechnology
$50K19 Dec 2022 Washington, District of Columbia, United States

Turbine

Artificial Intelligence
Biopharma
Biotechnology
$23M22 Nov 2022 Budapest, Hungary

CancerIQ

Analytics
Big Data
Genetics
Information Technology
Medical
SaaS
$14M03 Mar 2022 Chicago, Illinois, United States

Koneksa Health

Analytics
Big Data
Health Care
$45M07 Feb 2022 New York, New York, United States

TagNTrac

Internet of Things
Logistics
PaaS
Supply Chain Management
Wireless
$10M25 Jan 2022 San Diego, California, United States
News
Carlyle and Leading Healthcare-Focused Venture Funds Announce Strategic Growth Investment of up to $430 Million in Saama

– Saama technologies announced a strategic growth investment and will be acquired by Carlyle.
– Saama’s intelligent Life Science Analytics Cloud (LSAC) is used by over 50 pharma and biotech companies on more than 1,500 studies.
– As an end-to-end platform, LSAC provides a unified approach to clinical trial data management and analytics.
– Carlyle has made a strategic growth investment and will acquire a majority stake in the Company.
– A broad co-investor group with several healthcare-focused venture funds, including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners, will be investing alongside Carlyle.

Transcarent Raises $58 Million in Series B Funding to Accelerate Consumer-Directed Health and Care Experience for Self-Insured Employers

– Transcarent, a new and different consumer-directed health and care experience for employees of self-insured employers and their families, announced a $58m Series B investment led by General Catalyst and 7wireVentures, with participation from Merck Global Health Innovation Fund, Kleiner Perkins, Leaps by Bayer, GreatPoint Ventures, and Threshold Ventures along with existing investors Alta Partners and Jove Equity Partners.
– This round brings Transcarent’s total funding to $98m and will allow the company to respond to the demand for rapid expansion of its innovative risk-based offering for self-insured employers.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Merck Global Health Innovation Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 96
Average round size 27M
Rounds per year 6.86
Peak activity year 2015
Lead investments 11
Follow on index 0.42
Exits 22
Group Appearance index 0.80

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Unnatural Products

Artificial Intelligence
Biotechnology
Health Care
$32M19 Dec 2023 California, United States

Culmination Bio

Biotechnology
Health Care
$10M30 Nov 2023 -

Octave Bioscience

Biotechnology
Clinical Trials
Health Care
Health Diagnostics
Medical
$32M26 Jul 2023 California, United States

VastBiome

Biotechnology
Predictive Analytics
Therapeutics
$10M23 Mar 2023 California, United States

IndyGeneUS AI

Biotechnology
$50K19 Dec 2022 Washington, District of Columbia, United States

Turbine

Artificial Intelligence
Biopharma
Biotechnology
$23M22 Nov 2022 Budapest, Hungary

CancerIQ

Analytics
Big Data
Genetics
Information Technology
Medical
SaaS
$14M03 Mar 2022 Chicago, Illinois, United States

Koneksa Health

Analytics
Big Data
Health Care
$45M07 Feb 2022 New York, New York, United States

TagNTrac

Internet of Things
Logistics
PaaS
Supply Chain Management
Wireless
$10M25 Jan 2022 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: